During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

Any investor hoping to reap the rewards by holding marijuana companies must be a shiny-eyed optimist at this point. Weed ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.iXkfgCgn.js ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage ...

However, we see little synergies across Tilray's portfolio of cannabis, alcoholic beverages, and wellness products as the markets, distribution systems, and regulatory systems are vastly different.

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Tilray Brands is positioned as a leader in the cannabis beverage market in Canada, indicating strong brand recognition and market share. The introduction of new products like Mollo Seltzers and ...

As millions of Americans attempt a month without alcohol, some see an opportunity for hemp-derived alternatives over ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Tilray (TLRY – Research Report) today and set a price target of $2.00. The ...

Tilray Brands, Inc. (NASDAQ ... in over 20 countries with businesses in medical adult-use cannabis, beverages, spirits, wellness products, and a vast array of consumer-connected lifestyle brands.